NEWS!
- 04/2026
The Programme for 2026 has restarted with mass separation of external targets or long-lived CERN sources, with an exciting scientific programme ahead combining proof-of-concept and clinical translation of MEDICIS High Molar Activity grade radionuclides.
- 01/2026
Happy new year from the MEDICIS team and support groups !
- 01/2026
PRISMAP has delivered its last radionuclide last December, the programme coordinated by CERN with MEDICIS mass separation had been a large success, as reported now on CERN website .
JOB OPPORTUNITIES
Inorganic Radiopharmaceutical Chemist - Staff (assistant level) at Dpt Nucl Sciences Engineering (DECN), Instituto Superior Técnico (IST), University of Lisbon. Sept 30 - inquiries towards Dr. Antonio Paulo.
e
A KNOWLEDGE TRANSFER SUCCESS STORY
GRANTS & DONATIONS - CERN & Society Foundation
The CERN KT-Fund
La Fondation pour l'innovation sur le cancer et la biologie
The ADAM company
The FWO
